Hong Kong Insurance Stock News

MMG Limited recently reported its fourth-quarter and full-year 2025 production results alongside detailed 2026 production and C1 cost guidance for its major copper and zinc operations, including Las Bambas, Kinsevere, Khoemacau, Dugald River and Rosebery. A distinctive feature of the update is Rosebery’s 2026 C1 cost outlook, where by-product credits are expected to drive zinc cash costs below zero on a per‑pound basis. We’ll now examine how MMG’s 2026 cost and production guidance,...

Tiangong International announced that its subsidiary Jiangsu Tiangong Aihe Technology was approved on 16 January 2026 to join the Institute of Energy, Hefei Comprehensive National Science Center’s joint laboratory for developing fusion-oriented advanced metallic materials, including large-scale powder metallurgy 304B7 high-boron steel and new neutron shield steel. This collaboration gives Tiangong direct involvement in controlled nuclear fusion material research, potentially broadening...

Blue Moon Group Holdings (SEHK:6993) issued new earnings guidance, telling investors it expects at least a 50% reduction in its 2025 loss compared with the HK$749.3 million loss recorded for 2024. See our latest analysis for Blue Moon Group Holdings. That guidance landed alongside a 1 day share price return of 4.56% and a year to date share price return of 8.76% at HK$2.98. However, the 1 year total shareholder return of 13.58% and 5 year total shareholder return of 77.98% show that longer...

Why MicroPort Scientific’s latest guidance matters MicroPort Scientific (SEHK:853) has told investors it expects a turnaround to profitability in 2025, guiding to net profit of at least US$20 million after reporting an audited 2024 net loss of about US$268 million. See our latest analysis for MicroPort Scientific. The guidance appears to have arrived alongside a shift in sentiment, with a 1 month share price return of 18.17% and year to date share price return of 19.81%. The 1 year total...

Kuaishou Technology recently completed multi-currency fixed-rate senior unsecured bond offerings, raising about US$1.49 billion and CNY 3.50 billion with maturities extending to 2036, while reporting December 2025 monthly revenue above US$20 million. At the same time, its AI video-generation tool Kling surpassed 12 million monthly active users, underscoring how artificial intelligence is becoming a core pillar of Kuaishou’s business model and product appeal. We’ll now examine how the...

Earlier this month, Akeso announced that China’s National Medical Products Administration accepted its supplemental New Drug Application for gumokimab (AK111), an anti‑IL‑17A antibody for active ankylosing spondylitis, supported by positive Phase III data. This milestone highlights Akeso’s expanding non‑oncology portfolio and the potential for gumokimab to address a large ankylosing spondylitis patient population in China. We’ll now examine how gumokimab’s sNDA acceptance, supported by...

Key Insights Significant insider control over Skyworth Group implies vested interests in company growth The largest...

Key Insights Significant control over VISEN Pharmaceuticals by public companies implies that the general public has...

With its stock down 15% over the past three months, it is easy to disregard TUHU Car (HKG:9690). But if you pay close...

Most readers would already be aware that EPS Creative Health Technology Group's (HKG:3860) stock increased...

While some are satisfied with an index fund, active investors aim to find truly magnificent investments on the stock...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Ching Lee Holdings Limited's ( HKG:3728 ) price-to-earnings (or "P/E") ratio of 7.5x might make it look like a buy...

With a median price-to-earnings (or "P/E") ratio of close to 13x in Hong Kong, you could be forgiven for feeling...

While Huili Resources (Group) Limited ( HKG:1303 ) shareholders are probably generally happy, the stock hasn't had...

Viva Biotech Holdings ( HKG:1873 ) shareholders are no doubt pleased to see that the share price has bounced 28% in the...

JTF International Holdings Limited ( HKG:9689 ) shareholders have had their patience rewarded with a 54% share price...

Despite an already strong run, Sheung Yue Group Holdings Limited ( HKG:1633 ) shares have been powering on, with a gain...

Key Insights The considerable ownership by private companies in China National Building Material indicates that they...

Despite an already strong run, Vision Values Holdings Limited ( HKG:862 ) shares have been powering on, with a gain of...

Key Insights The considerable ownership by individual investors in Shanghai Fudan Microelectronics Group indicates that...

China Unicom (Hong Kong) Limited recently appointed Dong Xin as both Chairman and Chief Executive Officer, effective January 14, 2026, consolidating its top leadership roles under a single executive. By bringing in the existing head of China United Network Communications Group and China United Network Communications Corporation, the company is tightening alignment with its state-owned parent structure, which could influence future corporate priorities and governance. We will now examine...

WuXi Biologics recently announced that its Wuxi Drug Product Facility 5 and Drug Product Packaging Center received UK MHRA GMP certifications for commercial ophthalmic biologic manufacturing, alongside the launch of its PatroLabTM digital twin platform for real-time bioprocess monitoring and control. Together, these developments highlight WuXi Biologics’ growing role as a globally compliant manufacturer that is integrating advanced digital technologies to enhance biologics quality and...

If you are wondering whether Industrial and Commercial Bank of China is still offering value at current levels, this article will walk through what the market price might be implying about the stock. The share price recently closed at HK$6.17, with returns of 27.4% over 1 year and 84.4% over 3 years. However, the 7 day return of a 2.7% decline and the year to date return of a 2.7% decline show that the ride has not been one way. Recent news coverage has focused on ICBC's role as one of...